Bivalent RSV Prefusion F Vaccine to Prevent Hospitalizations in Adults
NEJM Evidence · 22.09.2026 · 5 (10)
DOI: 10.1056/evidoa2600272 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift NEJM Evidence, erschienen am 22.09.2026. Verfasst von Mats C H Lassen und 56 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Hospitalization, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
- Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Pfizer, New York, NY, USA.
- Genetics, Vaccines and Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Galicia, Spain.
- WHO Collaborating Centre for Vaccine Safety, Santiago de Compostela, Galicia, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Zitieren
APA
Lassen, M. C. H., Christensen, S. H., Yafasov, M., Pareek, M., Johansen, N. D., Rudolph, A. E., R-T Sánchez, C., Skaarup, K. G., Modin, D., Claggett, B. L., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Lindholm, M. G., Jensen, A. M. R., Dons, M., Bernholm, K. F., Davidovski, F. S., …, & Biering-Sørensen, T. (2026). Bivalent RSV Prefusion F Vaccine to Prevent Hospitalizations in Adults. NEJM Evidence, 5(10). https://doi.org/10.1056/evidoa2600272
Vancouver
Lassen MCH, Christensen SH, Yafasov M, Pareek M, Johansen ND, Rudolph AE, et al. Bivalent RSV Prefusion F Vaccine to Prevent Hospitalizations in Adults. NEJM Evidence. 2026;5(10). doi:10.1056/evidoa2600272
BibTeX
@article{Lassen2026,
author = {Lassen, Mats C H and Christensen, Sine H and Yafasov, Marat and Pareek, Manan and Johansen, Niklas Dyrby and Rudolph, Abby E and R-T Sánchez, Carmen and Skaarup, Kristoffer Grundtvig and Modin, Daniel and Claggett, Brian L and Larsen, Carsten S and Larsen, Lykke and Wiese, Lothar and Dalager-Pedersen, Michael and Lindholm, Matias G and Jensen, Anne Marie R and Dons, Maria and Bernholm, Katrine F and Davidovski, Filip S and Duus, Lisa Steen and Ottosen, Camilla I and Nielsen, Anne B and Borchsenius, Julie H and Espersen, Caroline and Köse, Guldas and Fussing, Frederik H and Lenz, Ingrid T and Christensen, Jacob and Simonsen, Jakob Ø and Afzal, Majid and Bartholdy, Katja V and Langhoff, Adam C F and Køber, Lars and Solomon, Scott D and Jensen, Jens Ulrik Stæhr and Martel, Cyril Jean-Marie and Giné-Vázquez, Iago and Duran-Parrondo, Carmen and Piñeiro-Sotelo, Marta and Cribeiro-González, Martín and Conde-Pájaro, Mónica and Mirás-Carballal, Susana and González-Pérez, Juan-Manuel and Gessner, Bradford D and Aliabadi, Negar and Schwarz, Claudia and Skovdal, Mette and Moulton, Lawrence H and Zhang, Pingping and López-Gómez, Vanessa and Welsh, Sabrina and Anatale-Tardiff, Laura and Cane, Alejandro and Hayford, Kyla and Martinón-Torres, Federico and Begier, Elizabeth and Biering-Sørensen, Tor},
title = {Bivalent RSV Prefusion F Vaccine to Prevent Hospitalizations in Adults},
journal = {NEJM Evidence},
year = {2026},
volume = {5},
number = {10},
doi = {10.1056/evidoa2600272}
}
EUVIMED